Advertisements



Apellis Pharmaceuticals Presses On With Late-Stage Studies After Trial Enrollment Pause

Apellis Pharmaceuticals Presses On With Late-Stage Studies After Trial Enrollment Pause.....»»

Category: topSource: seekingalphaMar 15th, 2019

Intercept Shares Soar To Multimonth High After NASH Drug Aces Late-Stage Trial

Intercept Pharmaceuticals Inc (NASDAQ: ICPT) — which is a frontrunner along with Gilead Sciences, Inc. read more.....»»

Category: blogSource: benzingaFeb 19th, 2019

Supernus Gets Crushed Despite Positive ADHD Study Results

Supernus Pharmaceuticals shares dipped on Thursday despite the firm posted positive results from two of its late-stage studies in children for the treatment of attention deficit hyperactivity........»»

Category: blogSource: 247wallstDec 6th, 2018

Regeneron"s Dupixent Meets Goals in Nasal Polyps Studies

Regeneron's (REGN) atopic dermatitis drug, Dupixent meets goals in two late-stage studies for nasal polyps. Regeneron Pharmaceuticals, Inc. REGN and p.....»»

Category: worldSource: nytOct 17th, 2018

Why Foamix Shares Are Booming

Foamix Pharmaceuticals shares were last seen up early on Wednesday after the company announced a solid performance in its late-stage trial for moderate-to-severe acne......»»

Category: blogSource: 247wallstSep 12th, 2018

Foamix stock surges 30% on positive late-stage results for acne medication

Foamix Pharmaceuticals Ltd. shares surged 30% in Wednesday premarket trade after the company reported positive late-stage trial results for its topical acne medication, FMX101. The phase 3 tria.....»»

Category: topSource: marketwatchSep 12th, 2018

Is Aquinox Pharmaceuticals Done?

Aquinox Pharmaceuticals saw its shares crash on Wednesday after the firm gave a disappointing update for a late-stage trial......»»

Category: blogSource: 247wallstJun 27th, 2018

Inovio Pharmaceuticals Reports 2018 Fourth Quarter and Year-End Financial Results

PLYMOUTH MEETING, Pa., March 12, 2019 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NASDAQ:INO), a late-stage biotechnology company focused on the development and commercialization of DNA immunotherapies targeted again.....»»

Category: earningsSource: benzingaMar 12th, 2019

Why Investors Are Hyped for Tonix Pharma’s PTSD Late-Stage Trial

Tonix Pharma shares made a solid gain on Monday after the firm announced that it is beginning to enroll patients in its late-stage study of Tonmya for the treatment of post-traumatic stress disorder......»»

Category: blogSource: 247wallstMar 11th, 2019

What’s Next for Horizon Pharma After This Late-Stage TED Trial

Horizon Pharma shares exploded on Thursday after the firm announced results from its late-stage trial evaluating teprotumumab for the treatment of active thyroid eye disease......»»

Category: blogSource: 247wallstFeb 28th, 2019

Novavax Re-Enters Penny Stock Territory After Respiratory Disease Vaccine Flunks Late-Stage Trial

Novavax, Inc. (NASDAQ: NVAX) shares were trading at less than $1 Thursday following the release of late-stage study results for its investigational vaccine candidate ResVax. read more.....»»

Category: blogSource: benzingaFeb 28th, 2019

Horizon Pharma announces positive results in late-stage trial of treatment for active thyroid eye disease

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»

Category: topSource: marketwatchFeb 28th, 2019

Idera Pharmaceuticals completes enrollment in Phase 2 ILLUMINATE-204 trial

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallFeb 27th, 2019

"Breakthrough" skin cancer drug at center of legal tussle between company, scientist, Oakland research center

A late-stage trial of the experimental gel at the center of the lawsuit started this month......»»

Category: topSource: bizjournalsFeb 21st, 2019

DelMar Pharmaceuticals reaches halfway enrollment point for VAL-083 trial

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallFeb 20th, 2019

Gilead Sciences Stock Tumbles on Disappointing Trial Data

The company said late-stage nonalcoholic steatohepatitis drug selonsertib didn’t meet its primary endpoint......»»

Category: topSource: barronsFeb 13th, 2019

Dash for NASH trips up Gilead, but "fatty liver disease" remains biotech target

A late-stage clinical trial by Gilead Sciences Inc. failed in fatty liver disease, the company said, sending a blow to a drug industry that has seen treatments for the disease as the next big thing. The Foster City-based company's (NASDAQ: GILD) s.....»»

Category: topSource: bizjournalsFeb 12th, 2019

Viking seen as possible Gilead target after NASH treatment fails in late-stage trial

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallFeb 12th, 2019

Gilead"s Failed NASH Drug Trial Drags Stock Lower

Gilead Sciences, Inc. (NASDAQ: GILD) is facing another setback, as its non-alcoholic steatohepatitis, or NASH, candidate Selonsertib flunked in a late-stage study. read more.....»»

Category: blogSource: benzingaFeb 12th, 2019

Gilead stock down nearly 4% as drug trial fizzles

Gilead Sciences Inc. shares fell 4% in the extended session Monday after the pharma company said a late-stage, placebo-controlled study des.....»»

Category: topSource: marketwatchFeb 11th, 2019

Can MacroGenics Keep Up the Pace After This Phase 3 Trial?

MacroGenics shares absolutely exploded on Wednesday after the firm announced late-stage results for its breast cancer trial......»»

Category: blogSource: 247wallstFeb 6th, 2019